KCM
EW icon

Kennedy Capital Management’s Edwards Lifesciences EW Stock Holding History

Kennedy Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5M Sell
137,826
-6,206
-4% -$520K 0.22% 166
2026
Q1 		$11.5M Sell
144,032
-2,280
-2% -$188K 0.24% 153
2025
Q4 		$12.5M Sell
146,312
-2,525
-2% -$207K 0.26% 136
2025
Q3 		$11.6M Sell
148,837
-26,943
-15% -$2.11M 0.26% 135
2025
Q2 		$13.7M Sell
175,780
-11,219
-6% -$837K 0.33% 84
2025
Q1 		$13.6M Sell
186,999
-5,519
-3% -$395K 0.32% 87
2024
Q4 		$14.3M Buy
192,518
+39,472
+26% +$2.76M 0.32% 74
2024
Q3 		$10.1M Buy
+153,046
New +$11.1M 0.22% 139
2024
Q2 		– Sell
-25,536
Closed -$2.44M – 716
2024
Q1 		$2.44M Buy
+25,536
New +$2.15M 0.05% 484

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Kennedy Capital Management's EW Position: Q2 2026 in Review

Kennedy Capital Management reduced its Edwards Lifesciences (EW) stake by 4.3% in Q2 2026, selling an estimated $520K and leaving 137,826 shares worth $12.5M. The position accounts for 0.22% of the portfolio, ranked #166.

Kennedy Capital Management first reported a position in EW in Q1 2024 and has held it in 9 quarters since. The position peaked at $14.3M in Q4 2024. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Kennedy Capital Management held 137,826 shares of Edwards Lifesciences worth $12.5M as of Q2 2026.
  • Kennedy Capital Management sold 6,206 Edwards Lifesciences shares in Q2 2026, an estimated $520K.
  • Edwards Lifesciences made up 0.22% of Kennedy Capital Management's portfolio in Q2 2026, its #166 holding.
  • Kennedy Capital Management first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 9 quarters since.
  • Kennedy Capital Management's Edwards Lifesciences position peaked at $14.3M in Q4 2024.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Kennedy Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.